Liothyronine sodium
Liothyronine sodium: 2 brands, 10 generics; first approved Jan 25, 1982; generic available.
Generic available: 10 ANDA applications approved.
Brand (NDA) products
- TRIOSTATRLDPH HEALTHNDA 0201051991
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.01MG BASE/ML INJECTABLE INJECTION Discontinued - - CYTOMELRLDKING PHARMSNDA 010379-3 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Rx AB EQ 0.025MG BASE TABLET ORAL Rx AB EQ 0.05MG BASE TABLET ORAL Rx AB
Generic (ANDA) products (10)
- LIOTHYRONINE SODIUMBIOCON PHARMAANDA 21807020243 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Rx AB EQ 0.025MG BASE TABLET ORAL Rx AB EQ 0.05MG BASE TABLET ORAL Rx AB - LIOTHYRONINE SODIUMZYDUS LIFESCIENCESANDA 21480320213 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Rx AB EQ 0.025MG BASE TABLET ORAL Rx AB EQ 0.05MG BASE TABLET ORAL Rx AB - LIOTHYRONINE SODIUMTEVA PHARMS USAANDA 21151020183 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Rx AB EQ 0.025MG BASE TABLET ORAL Rx AB EQ 0.05MG BASE TABLET ORAL Rx AB - LIOTHYRONINE SODIUMSUN PHARMANDA 09138220163 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Rx AB EQ 0.025MG BASE TABLET ORAL Rx AB EQ 0.05MG BASE TABLET ORAL Rx AB - LIOTHYRONINE SODIUMSIGMAPHARM LABS LLCANDA 20029520123 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Rx AB EQ 0.025MG BASE TABLET ORAL Rx AB EQ 0.05MG BASE TABLET ORAL Rx AB - LIOTHYRONINE SODIUMPHARMOBEDIENTANDA 09032620093 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Discontinued - EQ 0.025MG BASE TABLET ORAL Discontinued - EQ 0.05MG BASE TABLET ORAL Discontinued - - LIOTHYRONINE SODIUMDR REDDYS LABS SAANDA 09009720093 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.005MG BASE TABLET ORAL Rx AB EQ 0.025MG BASE TABLET ORAL Rx AB EQ 0.05MG BASE TABLET ORAL Rx AB - LIOTHYRONINE SODIUMRSXGEN PHARMSANDA 0769232005
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.01MG BASE/ML INJECTABLE INJECTION Rx - - LIOTHYRONINE SODIUMWATSON LABSANDA 0857531982
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.05MG BASE TABLET ORAL Discontinued - - LIOTHYRONINE SODIUMWATSON LABSANDA 0857551982
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.025MG BASE TABLET ORAL Discontinued -
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
Approvals span 1982–2024 across 12 FDA applications.
Liothyronine sodium: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Liothyronine sodium
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo